Ethinylestradiol/levonorgestrel
Combination of | |
---|---|
Ethinylestradiol | Estrogen |
Levonorgestrel | Progestogen |
Clinical data | |
Trade names | Altavera, Alysena, Amethyst, others[1] |
Other names | EE/LNG |
AHFS/Drugs.com | Monograph |
MedlinePlus | a601050 |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | |
KEGG |
Ethinylestradiol/levonorgestrel (EE/LNG) is a
ferrous fumarate.[4]
Side effects can include
implantation.[1]
Ethinylestradiol/levonorgestrel has been approved for medical use in the United States since 1982.
See also
References
- ^ a b c d e f g "Ethinyl estradiol and levonorgestrel medical facts from Drugs.com". www.drugs.com. Archived from the original on 1 January 2017. Retrieved 1 January 2017.
- ^ "Product monograph brand safety updates". Health Canada. February 2024. Retrieved 24 March 2024.
- ^ ISBN 9789241547659.
- ISBN 978-1-284-40304-6.
- ^ "Erlibelle 30micrograms/150micrograms film-coated tablets - Summary of Product Characteristics (SPC) - (eMC)". www.medicines.org.uk. Archived from the original on 2 January 2017. Retrieved 1 January 2017.
- hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ISBN 9781284057560.
- ^ "The Top 300 of 2021". ClinCalc. Archived from the original on 15 January 2024. Retrieved 14 January 2024.
- ^ "Ethinyl Estradiol; Levonorgestrel - Drug Usage Statistics". ClinCalc. Retrieved 14 January 2024.